Scarica l'app Stockscreener
34.04
4.00%
-1.42
Dopo l'orario di chiusura:
34.59
0.55
+1.62%
Precedente Chiudi:
$35.46
Aprire:
$33.88
Volume 24 ore:
372.82K
Relative Volume:
0.83
Capitalizzazione di mercato:
$1.57B
Reddito:
$1.08B
Utile/perdita netta:
$-20.76M
Rapporto P/E:
-74.00
EPS:
-0.46
Flusso di cassa netto:
$151.63M
1 W Prestazione:
-3.71%
1M Prestazione:
-9.78%
6M Prestazione:
-18.00%
1 anno Prestazione:
+23.47%
Intervallo 1D:
$33.52
$34.47
Intervallo di 1 settimana:
$33.52
$35.98
Portata 52W:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Nome
Omnicell Inc
Settore
Industria
Telefono
(877) 415-9990
Indirizzo
4220 NORTH FREEWAY, FORT WORTH
Confronta OMCL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
34.04 | 1.57B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
221.49 | 36.04B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
54.58 | 10.24B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
46.17 | 7.95B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
82.97 | 7.18B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.37B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-31 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Iniziato | Barclays | Underweight |
| 2023-11-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Reiterato | Wells Fargo | Underweight |
| 2023-08-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Iniziato | BofA Securities | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-12-06 | Ripresa | Wells Fargo | Overweight |
| 2021-06-09 | Iniziato | JP Morgan | Neutral |
| 2021-05-24 | Iniziato | BTIG Research | Buy |
| 2021-02-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-12-03 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-02-07 | Reiterato | Dougherty & Company | Buy |
| 2019-11-21 | Reiterato | Dougherty & Company | Buy |
| 2019-07-26 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-03-07 | Reiterato | Dougherty & Company | Buy |
| 2018-06-29 | Ripresa | The Benchmark Company | Buy |
| 2017-09-05 | Reiterato | The Benchmark Company | Buy |
| 2017-07-28 | Reiterato | Dougherty & Company | Buy |
| 2017-04-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Iniziato | Dougherty & Company | Buy |
| 2016-12-06 | Reiterato | The Benchmark Company | Buy |
| 2016-07-07 | Reiterato | FBR Capital | Outperform |
| 2016-03-21 | Reiterato | Topeka Capital Markets | Buy |
| 2016-01-07 | Iniziato | The Benchmark Company | Buy |
| 2015-11-16 | Reiterato | Topeka Capital Markets | Buy |
| 2015-10-30 | Reiterato | FBR Capital | Outperform |
| 2015-09-28 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-07-31 | Reiterato | Topeka Capital Markets | Buy |
Mostra tutto
Omnicell Inc Borsa (OMCL) Ultime notizie
OMCL CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to Make a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against Omnicell Inc. - ACCESS Newswire
Pharmacy Automation Market to Witness Remarkable Growth with - openPR.com
Consolidation at Omnicell - Pharmacy Magazine
Is The Market Rewarding Omnicell, Inc. (NASDAQ:OMCL) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - Yahoo Finance
India Pharmacy Automation Market Competition, Forecast & - GlobeNewswire
Omnicell (NASDAQ:OMCL) Downgraded to Hold Rating by StockNews.com - MarketBeat
Omnicell Names Veteran Surgical Robotics Exec as Its New CTO - Dallas Innovates
Omnicell Appoints New CTO to Drive Technological Innovation - Zenopa
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term - Yahoo Finance
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer - EnterpriseTalk
Omnicell appoints Perry Genova as new CTO By Investing.com - Investing.com South Africa
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Offi - GuruFocus
Omnicell appoints Perry Genova as new CTO - Investing.com India
Omnicell appoints Perry Genova as Chief Technology Officer -March 24, 2025 at 04:30 pm EDT - MarketScreener
Pharmacy Automation Systems Market is expected to grow at a CAGR - openPR.com
Healthcare Tech Expert with 25-Year Track Record Takes Tech Helm at Omnicell - Stock Titan
Pharmacy Automation Market Future Business Opportunities - openPR.com
Long Term Trading Analysis for (OMCL) - news.stocktradersdaily.com
What Analysts Are Saying About Omnicell Stock - Benzinga
Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)? - simplywall.st
Omnicell CEO Randall Lipps buys $349,874 in stock By Investing.com - Investing.com Australia
Omnicell CEO Randall Lipps buys $349,874 in stock - Investing.com India
Omnicell, Inc. (NASDAQ:OMCL) Given Average Recommendation of “Hold” by Brokerages - Defense World
Omnicell CFO Nchacha Etta to step down in September By Investing.com - Investing.com Australia
Omnicell's (NASDAQ:OMCL) Earnings Seem To Be Promising - Yahoo Finance
Omnicell Chief Financial Officer Nchacha Etta to Retire - citybiz
Fort Worth-Based Omnicell CFO Nchacha Etta to Step Down as Company Initiates National Search - Fort Worth Inc.
BofA cuts Omnicell stock target to $38, maintains neutral rating By Investing.com - Investing.com UK
Omnicell Announces Chief Financial Officer Transition - 01Net
Omnicell CFO to step down, co reiterates first quarter and full year outlook -March 12, 2025 at 10:28 am EDT - Marketscreener.com
Omnicell CFO to step down, co reiterates first quarter and full year outlook - TradingView
Omnicell, Inc. Announces Step Down of Nchacha Etta as Executive Vice President Effective September 15, 2025 - Marketscreener.com
Omnicell's CFO Nchacha Etta to Step Down; Reaffirms Q1, Fiscal 2025 Guidance -March 12, 2025 at 09:20 am EDT - Marketscreener.com
Omnicell CFO Nchacha Etta to step down in September - Investing.com
Omnicell CFO set to depart By Investing.com - Investing.com Canada
Omnicell CFO Nchacha Etta to step down - TipRanks
Omnicell CFO Nchacha Etta Announces Departure - TipRanks
OMCLOmnicell Com Latest Stock News & Market Updates - StockTitan
Omnicell, Inc. to Host Earnings Call - ACCESS Newswire
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Bank of New York Mellon Corp - Defense World
QRG Capital Management Inc. Sells 353 Shares of Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell (NASDAQ:OMCL) Raised to “Buy” at StockNews.com - Defense World
Omnicell Gains 41.6% in a Year: What's Driving the Stock? - MSN
Omnicell CEO secures employment agreement through 2027 By Investing.com - Investing.com Canada
Omnicell CEO secures employment agreement through 2027 - Investing.com
Omnicell Secures CEO Randall Lipps Through 2027 - TipRanks
Medication Management System Market Is Booming Worldwide - openPR
Omnicell Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
What is Zacks Research’s Forecast for Omnicell Q3 Earnings? - Defense World
FY2027 EPS Forecast for Omnicell Decreased by Analyst - Defense World
Omnicell FY2027 EPS Estimate Reduced by Zacks Research - MarketBeat
Omnicell Inc Azioni (OMCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Omnicell Inc Azioni (OMCL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
4.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):